Terms: = Gastric cancer AND COL1A1, P02452, 1277, ENSG00000108821, OI4
66 results:
1. A retrospective study: exploring the optimal patient population for adjuvant chemotherapy after D2 gastrectomy.
Zheng Y; Ma Y; Pang C; Yin K; Liu K; Chen J; Zi M; Wei Y; Cheng X; Yuan L
J Gastrointest Surg; 2024 Apr; 28(4):365-374. PubMed ID: 38583885
[TBL] [Abstract] [Full Text] [Related]
2. Tubulointerstitial nephritis antigen-like 1 from cancer-associated fibroblasts contribute to the progression of diffuse-type gastric cancers through the interaction with integrin β1.
Lee D; Ham IH; Oh HJ; Lee DM; Yoon JH; Son SY; Kim TM; Kim JY; Han SU; Hur H
J Transl Med; 2024 Feb; 22(1):154. PubMed ID: 38355577
[TBL] [Abstract] [Full Text] [Related]
3. Identification of differentially expressed genes associated with the pathogenesis of gastric cancer by bioinformatics analysis.
Abdolahi F; Shahraki A; Sheervalilou R; Mortazavi SS
BMC Med Genomics; 2023 Dec; 16(1):311. PubMed ID: 38041130
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer.
Li A; Li Y; Li Y; Zhang M; Zhang H; Chen F
PeerJ; 2023; 11():e16243. PubMed ID: 37868053
[TBL] [Abstract] [Full Text] [Related]
5. Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer.
Wang S; Yang X; Liu C; Hu J; Yan M; Ding C; Fu Y
Medicine (Baltimore); 2023 Oct; 102(40):e35111. PubMed ID: 37800754
[TBL] [Abstract] [Full Text] [Related]
6. Collagen 1A1 (col1a1) and Collagen11A1(COL11A1) as diagnostic biomarkers in Breast, colorectal and gastric cancers.
Salimian N; Peymani M; Ghaedi K; Hashemi M; Rahimi E
Gene; 2024 Jan; 892():147867. PubMed ID: 37783295
[TBL] [Abstract] [Full Text] [Related]
7. System biology analysis to develop diagnostic biomarkers, monitoring pathological indexes, and novel therapeutic approaches for immune targeting based on maggot bioactive compounds and polyphenolic cocktails in mice with gastric cancer.
Kaviani E; Hajibabaie F; Abedpoor N; Safavi K; Ahmadi Z; Karimy A
Environ Res; 2023 Dec; 238(Pt 2):117168. PubMed ID: 37742751
[TBL] [Abstract] [Full Text] [Related]
8. CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration.
Huang X; Liu Y; Qian C; Shen Q; Wu M; Zhu B; Feng Y
J Transl Med; 2023 Jul; 21(1):474. PubMed ID: 37461041
[TBL] [Abstract] [Full Text] [Related]
9. A multifactorial analysis of FAP to regulate gastrointestinal cancers progression.
Cai J; Yang D; Sun H; Xiao L; Han F; Zhang M; Zhou L; Jiang M; Jiang Q; Li Y; Nie H
Front Immunol; 2023; 14():1183440. PubMed ID: 37325617
[TBL] [Abstract] [Full Text] [Related]
10. Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator.
Sadegh K; Ahmadi A
IET Syst Biol; 2023 Jun; 17(3):131-141. PubMed ID: 37118990
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptome sequencing identifies prognostic genes involved in gastric adenocarcinoma.
Li M; Bai M; Wu Y; Yang S; Zheng L; Sun L; Yu C; Huang Y
Mol Cell Biochem; 2023 Dec; 478(12):2891-2906. PubMed ID: 36944795
[TBL] [Abstract] [Full Text] [Related]
12. gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression.
Gao Q; Cui L; Huang C; Chen Z; Wang X; Wen S; Zhao Y; Wang M; Shen B; Zhu W
Exp Cell Res; 2023 Jan; 422(1):113414. PubMed ID: 36368567
[TBL] [Abstract] [Full Text] [Related]
13. TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
[TBL] [Abstract] [Full Text] [Related]
14. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in gastric cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer.
Ucaryilmaz Metin C; Ozcan G
BMC Cancer; 2022 Jun; 22(1):692. PubMed ID: 35739492
[TBL] [Abstract] [Full Text] [Related]
16. Identification of hub pathways and drug candidates in gastric cancer through systems biology.
Salarikia SR; Kashkooli M; Taghipour MJ; Malekpour M; Negahdaripour M
Sci Rep; 2022 Jun; 12(1):9099. PubMed ID: 35650297
[TBL] [Abstract] [Full Text] [Related]
17. Bioinformatics Analysis and Identification of Potential Genes Associated with Pathogenesis and Prognosis of gastric cancer.
Wang DW; Su F; Yang LJ; Shi LW; Yang TC; Wang HQ; Li XF; Feng MH
Curr Med Sci; 2022 Apr; 42(2):357-372. PubMed ID: 35325407
[TBL] [Abstract] [Full Text] [Related]
18. HELICOBACTER PYLORI cagA VIRULENCE GENE AND SEVERE ESOGASTRODUODENAL DISEASES: IS THERE AN ASSOCIATION?
Oliveira AKS; Silva LLL; Miguel MP; Blanco AJV; Carneiro LC; Barbosa MS
Arq Gastroenterol; 2021; 58(4):468-475. PubMed ID: 34909852
[TBL] [Abstract] [Full Text] [Related]
19. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis.
Alatan H; Chen Y; Zhou J; Wang L
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118
[TBL] [Abstract] [Full Text] [Related]
20. RUNX2 promotes malignant progression in gastric cancer by regulating col1a1.
Li Y; Sun R; Zhao X; Sun B
Cancer Biomark; 2021; 31(3):227-238. PubMed ID: 33896817
[TBL] [Abstract] [Full Text] [Related]
[Next]
